Verition Fund Management »

Aclaris Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.1M 300k 6.85
2023-06-30 $6.8M 651k 10.37
2023-03-31 $5.0M 614k 8.09
2022-12-31 $6.4M 406k 15.75
2022-09-30 $5.9M 373k 15.74
2022-06-30 $4.7M 335k 13.96
2022-03-31 $4.4M 256k 17.24
2021-12-31 $2.6M 178k 14.54
2020-12-31 $640k 99k 6.47
2020-06-30 $105k 65k 1.62